NCGC00024928-02

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

30 Suppliers, 11 USDMF, 6 CEP/COS, 2 JDMF, 4 KDMF, 14 NDC API, 19 Listed Suppliers

DEVELOPMENTS

11 Drug(s) in Development

11 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

INTERMEDIATES

8 Suppliers

8 Suppliers

DOSSIERs // Finished Dosage Forms

112 Dossiers, 26 FDA Orange Book, 46 Europe, 6 Canada, 7 Australia, 9 South Africa, 18 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;ORAL - EQ 20MG BASE/10ML

RELATED EXCIPIENT COMPANIES

Suppliers, 37 Kerry, 28 Roquette, 24 BASF, 17 Microlex e.U, 17 SPI Pharma, 11 Gangwal Healthcare, 10 Corel Pharma Chem, 10 Sigachi Industries, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 7 Gangwal Chemicals, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 7 Seppic, 6 DFE Pharma, 6 Lonza Capsugel, 5 Ideal Cures Pvt Ltd, 5 Actylis, 4 Nanjing Well Pharmaceutical, 4 Ingredion Pharma Solutions, 4 Kima Chemical, 4 Prachin Chemical, 3 Vasa Pharmachem, 3 Rochem International Inc, 3 The Dow Chemical Company, 3 Boai NKY Pharmaceuticals Ltd, 2 Ulanqab Kema New Material, 2 Nomisma Healthcare, 2 Pharmatrans-Sanaq, 2 DKSH, 2 Shijiazhuang Huaxu Pharmaceutical, 2 Seqens, 2 Finar, 1 Clariant, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Jai Radhe Sales, 1 Pfanstiehl, 1 ACG Worldwide, 1 Qualicaps, 1 Zhejiang Huakang Pharmaceutical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Bioplus Life Sciences

EXCIPIENTS BY APPLICATIONS

87 Fillers, Diluents & Binders, 49 Coating Systems & Additives, 37 Direct Compression, 28 Controlled & Modified Release, 25 Granulation, 24 Disintegrants & Superdisintegrants, 24 Thickeners and Stabilizers, 21 Taste Masking, 19 Film Formers & Plasticizers, 17 Solubilizers, 16 Co-Processed Excipients, 16 Chewable & Orodispersible Aids, 14 Parenteral, 13 Lubricants & Glidants, 11 Topical, 6 API Stability Enhancers, 6 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules, 3 Emulsifying Agents, 2 Coloring Agents, 1 Surfactant & Foaming Agents, 1 Soft Gelatin

GLOBAL SALES INFORMATION

16 US Medicaid Prescriptions, 45 Finished Drug Prices

MARKET PLACE

6 APIs, 9 DOSSIERS // FDF

ANALYTICAL SOLUTION(s)

3 EDQM Standards, 1 USP Standards, 1 Other Ref. Standards

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow, 23 News

Approved Drug Products containing NCGC00024928-02 listed with Health Canada. Original Data : Health Canada Website

NCGC00024928-02

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

30 Suppliers

11 USDMF

6 CEP/COS

2 JDMF

4 KDMF

14 NDC API

19 Listed Suppliers

DEVELOPMENTS

11 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Imports

INTERMEDIATES

8 Suppliers

DOSSIERs // Finished Dosage Forms

112 Dossiers

26 FDA Orange Book

46 Europe

6 Canada

7 Australia

9 South Africa

18 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;ORAL - EQ 20MG BASE/10ML

RELATED EXCIPIENT COMPANIES

Suppliers

37 Kerry

28 Roquette

24 BASF

17 Microlex e.U

17 SPI Pharma

11 Gangwal Healthcare

10 Corel Pharma Chem

10 Sigachi Industries

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

7 Gangwal Chemicals

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

7 Seppic

6 DFE Pharma

6 Lonza Capsugel

5 Ideal Cures Pvt Ltd

5 Actylis

4 Nanjing Well Pharmaceutical

4 Ingredion Pharma Solutions

4 Kima Chemical

4 Prachin Chemical

3 Vasa Pharmachem

3 Rochem International Inc

3 The Dow Chemical Company

3 Boai NKY Pharmaceuticals Ltd

2 Ulanqab Kema New Material

2 Nomisma Healthcare

2 Pharmatrans-Sanaq

2 DKSH

2 Shijiazhuang Huaxu Pharmaceutical

2 Seqens

2 Finar

1 Clariant

1 Shanghai Welltone Material Technology Co., Ltd

1 Jai Radhe Sales

1 Pfanstiehl

1 ACG Worldwide

1 Qualicaps

1 Zhejiang Huakang Pharmaceutical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Bioplus Life Sciences

EXCIPIENTS BY APPLICATIONS

87 Fillers, Diluents & Binders

49 Coating Systems & Additives

37 Direct Compression

28 Controlled & Modified Release

TABLET;ORAL - EQ 10MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 20MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons